Sugar Editorial Picks
Jul 05, 2007 -
The national Center for Excellence in Rural Safety (CERS) at the University of Minnesota recently released a list of the states where Americans are more likely to die in a traffic crash on a rural road. To see where your state falls in the top 15 most dangerous states to drive, read more
- 19 Comments
Other Search Results
Oct 13, 2009 -
I can't make it more than a few miles without some driving tunes in my ear, so running a 25 mile race sans iPod would be out of the question. Thankfully, I'm not looking to win a marathon anytime soon, but if I was, I'd know that running with an iPod is a dangerous move if I want to take home the gold. Take for example, the winner of the recent Milwaukee Lakefront Marathon winner, Jennifer Goebel, who was disqualified after being photographed during the race with an iPod in her pocket.
- 28 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes of Short-Term or Tra...
- Causes of Chronic Insomnia...
- Risk Factors
- Prognosis
- Diagnosis
- Treatment
- Medications
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Sedative Hypnotic Drug Warnings
In March 2007, the FDA ordered stronger warning labels on sedative hypnotic drugs. These medications include benzodiazepine and non-benzodiazepine drugs, such as zolpidem (Ambien), eszopiclone (Lunesta), ramelteon (Rozerem), and triazolam (Halcion). The FDA warned that these drugs may be associated with:
- Severe allergic reactions (anaphylaxis) and severe facial swelling (angioedema), which can occur even the first time a drug is taken
- Complex sleep-related behaviors, such as sleep driving, making phone calls, and preparing and eating food while asleep
Patients who take sleeping pills should be sure to follow the directions.
- 5 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Complications
- Diagnosis
- Treatment
- Medications
- Other Treatments
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In 2007, duloxetine (Cymbalta) was approved for treatment of generalized anxiety disorder. Duloxetine is a dual inhibitor antidepressant.
Anxiety Disorders Under-Recognized and Under-Treated
About 41% of patients with an anxiety disorder do not receive any treatment, indicates a 2007 study in the Annals of Internal Medicine.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Symptoms
- Complications
- Diagnosis
- Treatment
- Lifestyle Changes
- Abdominal Infections
- Encephalopathy
- Ascites
- Bleeding Episodes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In 2007, the Food and Drug Administration approved HepaGram B, an injectable immune globulin that can help prevent recurrence of hepatitis B following liver transplantation.
Primary Biliary Cirrhosis
Primary biliary cirrhosis is an autoimmune liver disease that increases the risk for liver cancer. According to a 2007 study, specific risk factors may help predict which patients with primary biliary cirrhosis are at particularly high risk of developing liver cancer.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Prognosis
- Risk Factors
- Diagnosis
- Managing Heart Disease
- Anti-Clotting Medications...
- Other Medications
- Surgery
- Coronary Artery Bypass Graf...
- Angioplasty and Stents
- Other Treatments
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Angioplasty Versus Drugs
Angioplasty works no better than drug therapy (high blood pressure, cholesterol, anti-platelet, and other medication) in preventing heart attack and stroke in patients with stable coronary artery disease (CAD), according to an important New England Journal of Medicine study. Experts still recommend angioplasty for patients with unstable or severe CAD.
Stents
- Stents coated with drugs may have a slightly higher risk of causing blood clots than bare metal stents, according to FDA meetings held in late 2006.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Outlook and Effects
- Diagnosis
- Treatment
- Treatment After The First S...
- Medications
- Surgery
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In 2007, the Food and Drug Administration (FDA) approved levetiracetam (Keppra) for treatment of primary generalized tonic-clonic seizures in adults, and children ages 6 years and older, who have idiopathic generalized epilepsy. Levetiracetam was previously approved for partial-onset seizures and myoclonic seizures.
Carbamazepine and Genetic Testing
In 2007, the FDA recommended that patients of Asian ancestry get a genetic test prior to taking carbamazepine (Tegetrol, Equetro, Carbatrol).
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Risk Factors
- Causes
- Complications of Bulimia...
- Complications of Anorexia...
- Symptoms
- Diagnosis
- Treatment
- Treatment for Bulimia
- Treatment for Anorexia
- Therapy
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Eating Disorders Overview
- Eating disorders typically occur among young women.
- Bulimia nervosa involves a pattern of bingeing and purging. Many people with bulimia nervosa also suffer from depression.
- Anorexia nervosa involves a pattern of self-starvation. Patients often have an accompanying anxiety disorder (such as obsessive compulsive disorder) or depression.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Biological and Medical Caus...
- Cultural and Emotional Caus...
- Risk Factors
- Complications
- Weight Loss and Maintenance...
- Weight Management
- Medications
- Other Treatments
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Cancer and Weight Control:
- Cancer prevention guidelines from the American Cancer Society stress the importance of maintaining a healthy weight throughout life. A healthy weight is even more important than eating specific healthy foods, when it comes to cancer prevention.
Drug Warning:
- The US Food and Drug Administration (FDA) is warning consumers not to buy a product known as the "Brazilian diet pill." This product is labeled as a dietary supplement, but contains several chemicals found in powerful prescription drugs.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Risk Factors
- Causes
- Prognosis
- Diagnosis
- Treatment
- Medications
- Other Treatments
- Therapy and Lifestyle Chang...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In 2007, the FDA approved risperidone (Risperdal) for short-term treatment of manic or mixed episodes of bipolar I disorder in children ages 10 - 17. Risperidone (an atypical antipsychotic) and lithium (a mood stabilizer) are the two drugs currently approved for treating pediatric patients with bipolar disorder.
Drug Warnings
- Olanzapine (Zyprexa, Symbex) causes a greater risk for high blood sugar than other atypical antipsychotics, according to updated information added to the drug’s warning label.
- 1 Comment